TOKYO -- Japanese drug developers are preparing novel vaccines for the market, designed to combat the spread of dengue fever, cholera and malaria by using the latest in biopharmaceutical technology.
Takeda Pharmaceutical will apply for approval of its dengue fever vaccine next year, hoping to launch the product in 2020. The company will supply the vaccine in Latin American and Asian countries where many of the 3.9 billion people at risk of contracting the disease live.
